Register to attend a free NIH webinar. Attendees will learn about a new family of Proteolysis Targeting Chimeras (PROTACS) that selectively target Proviral Integration for the Moloney murine leukemia virus [….]
NCI Technology Opportunities Webinar: An Adjuvanted Mucosal Subunit Vaccine for Preventing SARS-CoV-2 Transmission and Infection
Published on :Register to attend a free NIH webinar. Attendees will learn about a new adjuvanted subunit mucosal COVID-19 vaccine. Study results show this new vaccine prevents SARS-CoV-2 transmission and infection. Most [….]
NIH Technology Opportunity Webinar: Automated Acoustophoresis Benchtop Device to Radio-Label & Isolate Cells for Immunotherapy Treatment
Published on :Register to attend a free NIH webinar. Attendees will learn about the research behind a proposed, automated benchtop device for labeling immunotherapy cells with 89Zr-oxine for Positron Emission Tomography (PET) [….]
NCI Technology Opportunity Webinar: Anti-EGFR Antibodies for the Treatment of Human Cancers
Published on :Register to attend a free NIH webinar. Attendees will learn about new antibodies developed in Dr. David Fitzgerald’s Lab that bind a particular structure on the external domain of epidermal [….]
NCI Technology Opportunities Webinar: GPC1 as a New Therapeutic Target in Pancreatic Cancer: Development of Antibodies and CAR-T
Published on :Register to attend a free NIH webinar. Attendees will learn about a new targeted immunotherapy pancreatic cancer treatment centered on the Glypican-1 (GPC1) cell surface heparan sulfate proteoglycan protein which [….]
2023 National Cancer Institute and Frederick National Laboratory Technology Showcase
Registration is open for the 2023 Technology Showcase, the annual event highlighting how potential industry partners can work with the NCI and Frederick National Laboratory (FNL). You can choose to attend either in-person at the Frederick National Laboratory or online.
Maryland Life Science Advisory Board Welcomes New Members
The Life Sciences Advisory Board added three new members, Ellington West of Sonavi Labs, Michael Weingarten of the National Cancer Institute, and GlaxoSmithKline’s KaShauna G. Rohlehr.
How to Partner with the Frederick National Lab and National Cancer Institute
Both the FNL and NCI look for partnerships that can aid their work while providing their partners’ resources and expertise. The lab’s partners often include big pharmaceutical and biotech companies that are more product-driven than NCI and FNL, which are more research-driven.
National Cancer Institute (NCI) Awards Baltimore’s Isoprene Pharmaceuticals, Inc. a Two-Year $2 Million Small Business Innovation Research (SBIR) Grant
University of Maryland, Baltimore (UMB) startup is part of University’s New Ventures Initiative, a highly selective program that works to accelerate commercialization and exit strategies
Gaithersburg’s miRecule Inc. closes $5.7M to Create Breakthrough RNA Therapies for Cancer and Muscular Dystrophy
miRecule, Inc. (“miRecule”), an emerging biotech company focused on the development of cutting-edge RNA therapeutics, announced today it has closed over $5.7M in seed funding. The funding round was led by Alexandria Venture Investments, along with Boutique Venture Partners, Pathway Bioventures, Alumni Ventures Group, and national angel investors, with additional funding coming from the Maryland Momentum Fund and the FSHD Society. This funding includes a non-dilutive $2M Phase II SBIR grant from the National Cancer Institute.